Insights

Featured Content

Case Study- Technology

Case Study: Wireless Communications Expert Needed for PTAB Proceedings

A technology company petitioned for IPR proceedings to challenge the validity of two wireless communications patents, arguing that the patented methods were already established industry practices.

An Automotive Expert’s 2025 Outlook: What’s Next for EVs, AI, and IP Disputes

To gain a deeper understanding of the conflicts and legal challenges shaping the 2025 landscape and beyond, we asked WIT Panel Member and automotive industry expert, Julie Wurmlinger, for her thoughts on the industry’s legal landscape.

2024 in Review: Key ITC Insights Report

WIT's second annual ITC report, 2024 in Review: Key ITC Insights, provides a comprehensive look at 2024's activities and trends at the ITC. Learn more about our findings.

Case Study- Technology

Case Study: Automotive Manufacturing Expert Needed for Patent Dispute

A major vehicle manufacturer was accused of patent infringement regarding its automated assembly and quality control systems. WIT provided an industry expert to determine whether the disputed technology was an industry standard or a novel invention.

2024 in Review: Analyzing Hatch-Waxman Litigation Trends

Our latest Hatch-Waxman report, 2024 in Review: Analyzing Hatch-Waxman Litigation Trends, provides a comprehensive look at 2024’s activities and trends in ANDA litigation.

Insights & News

Pharmaceutical

All Focus Areas
Automotive
Cryptocurrency
Financial Technology
Gaming
Hatch-Waxman Litigation
Healthcare Technology & Medical Devices
ITC Investigations
Pharmaceutical
Wireless Communications

All Insight Types

All Insight Types
Archive
Blog
Case Study
Case Study- Life Sciences
Case Study- Technology
Event
In the News
Other Content
Press Release
Q&As
Report
Video

February 18, 2025 — Q&As

Rethinking Experience: Why New Expert Witnesses Deserve a Closer Look

To explore the value of emerging testifying experts, we spoke with several members of the WIT team to gain insights on addressing client concerns, shifting perceptions, and how strategic preparation can turn fresh talent into indispensable litigation assets.

February 3, 2025 — Press Release

WIT Legal Releases 2nd Annual Report on Trends in Hatch-Waxman Litigation

The new report examines Abbreviated New Drug Application (ANDA) cases and the Orange Book-listed products at issue throughout 2024.

January 31, 2025 — Report

2024 in Review: Analyzing Hatch-Waxman Litigation Trends

Our latest Hatch-Waxman report, 2024 in Review: Analyzing Hatch-Waxman Litigation Trends, provides a comprehensive look at 2024’s activities and trends in ANDA litigation.

January 13, 2025 — Q&As

A Conversation with WIT’s Hatch-Waxman Practice Chair: Examining 2024 ANDA Litigation Activity

Recently, we spoke to our Hatch-Waxman Practice Chair, Michael Crowe, to gain insights into Hatch-Waxman litigation trends in 2024. Here’s what he had to say about filings and possible trends in the year ahead.

December 18, 2024 — Report

WIT Hatch-Waxman Report: Judge Michael Shipp

Our latest Hatch-Waxman report provides a comprehensive analysis of Judge Michael Shipp's activity at the United States District Court for the District of New Jersey since his appointment in July 2012. Learn more about our findings.

December 12, 2024 — Blog

Expert Qualifications Under Revised FRE 702: A Look at Recent Cases

The 2023 amendment to Federal Rule of Evidence (FRE) 702 has introduced stricter standards for expert testimony, challenging litigators to adapt to the evolving requirements. Let’s take a look at five recent cases to see how courts are putting these requirements into practice—insights that will prove particularly valuable for litigators planning their expert strategy.

December 4, 2024 — Case Study- Life Sciences

Case Study: Medical Device Expert Needed for Cardiovascular Patent Dispute Before the PTAB

The petitioner challenged the validity of several patents covering catheter-based delivery systems for heart valve replacement. The patent owner turned to WIT for an expert in cardiovascular medical devices and regulatory processes.

November 6, 2024 — Blog

Perspectives on the Amendment to Rule 702

To better understand how the amendment is reshaping the way expert testimony is being handled, we contacted key stakeholders for their insights. From the perspectives of an attorney, expert liaison, and expert witness, these changes are prompting more thorough vetting and strategic planning in selecting experts for matters.

October 25, 2024 — Q&As

Q&A: The Impact of Changes to Federal Rule of Evidence 702

We asked WIT CEO Paul Neale to share his thoughts on the implications of the FRE 702 amendment and the proactive measures attorneys can take to ensure their expert witnesses withstand greater judicial scrutiny.

October 23, 2024 — Blog

Life Sciences Roundup: Top Insights from Q2 – Q3

Life sciences companies face mounting litigation over patents, products, and pricing practices. Successfully navigating these matters requires expertise from qualified experts and an expert agency focused on arising litigation trends. Check out our insights.

Load More Loading...